BRIDGEBIO PHARMA INC

About

BridgeBio Pharma Inc. is a commercial-stage biopharmaceutical company focused on discovering, developing, and delivering transformative medicines for genetic diseases and cancers. The company operates a portfolio model, advancing multiple programs simultaneously through its subsidiary partners to target specific driver genetic mutations. BridgeBio aims to leverage this approach to provide high-impact therapies for patient populations with significant unmet medical needs.